Retrieved December 11, 2009
Course Highlights Discover how combining lifestyle modifications with GLP-1 receptor agonists can improve weight loss, glycemic control, and overall cardiometabolic health Examine the science behind GLP-1 receptor agonists, from their effects on insulin secretion and appetite regulation to next-generation agents like tirzepatide and orforglipron Learn best practices for patient education, dosing strategies, and interprofessional collaboration while addressing contraindications, adverse effects, and compounding warnings Introduction Obesity is a chronic and prevalent condition that impacts health, contributing to higher rates of morbidity and mortality
The advantage of the combination is biological coverage that no single peptide provides alone, but it also asks for more clinical oversight
They are particularly important in early-stage trials, especially Phase I studies, which focus on assessing the safety and tolerability of a drug before it is tested on patients
USA 112 , 68636870 (2015)
Interestingly, an underdevelopment in this field: exploration of NAMPT inhibitors in combination with inhibitors of immune checkpoints
